20/20NOW IMPLEMENTS RETINAL AI IN ALL OF ITS OCULAR TELEHEALTH EXAMS

October 5, 2018 —

ENABLING OPTOMETRISTS TO BETTER DIAGNOSE DIABETIC RETINOPATHY

 

NEW YORK, N.Y. 20/20NOW, the pioneer and innovator of Ocular Telehealth, recently announced their use of Artificial Intelligence (“AI”) to allow for the early detection of retinal disease such as diabetic retinopathy.  Through the use of FDA approved equipment and software, retinal images are immediately enhanced using the AI program, allowing optometrists to diagnose with more confidence conditions that affect the retina. With traditional testing, some retinopathy may go undetected in its early stages. Given the widespread epidemic of diabetes, optometrists who work with 20/20NOW’s Ocular Telehealth System are now able to utilize this cutting-edge technology to identify diabetic retinopathy and refer patients for treatment, which ultimately can prevent blindness and other health complications.

Read More

Philadelphia Eyeglass Labs chooses 20/20NOW to enhance and expand its ocular telehealth offering

September 24, 2018 —

PHILADELPHIA, PA, Philadelphia Eyeglass Labs, a five location eyecare practice in the greater Philadelphia area, and 20/20NOW, the inventor of ocular telehealth eye exams, announced that Philadelphia Eyeglass Labs has chosen 20/20NOW as its new Ocular Telehealth partner. Previously, Philadelphia Eyeglass Labs was working with Digital Optometrics and helped beta-test their system.

Read More

20/20NOW INCORPORATES RETINAL AI INTO ITS OCULAR TELEHEALTH EXAM TO PROVIDE EARLY DIAGNOSIS OF DIABETIC RETINOPATHY

September 13, 2018 —

NEW YORK, N.Y. 20/20NOW, the pioneer and innovator of Ocular Telehealth, has announced it’s now using Artificial Intelligence, to enable the early detection of diabetic retinopathy. Through the use of FDA approved equipment and software during 20/20NOW’s comprehensive telehealth exam, scientific algorithms are used to immediately enhance retinal images to identify lesions in the retina. Diabetic retinopathy if untreated, results in vision loss and ultimately blindness. These lesions are typically undetectable to the human eye. Identifying diabetic retinopathy in its early stages, when it’s most treatable, is critical to preventing blindness and lowering health care costs.

Read More

GVS partners with 20/20NOW to provide the first mobile eye care center using ocular telehealth

August 1, 2018 —

NEW YORK, N.Y., General Vision Services (GVS), a leading vision benefits provider, and 20/20NOW, the inventor of ocular telehealth eye exams, are partnering to create the first mobile eye care center featuring ocular telehealth. Commencing in August the center will provide on-site eyecare and eyewear services at GVS client locations. Members of GVS clients will be able to take care of all their optical needs while at work.

Read More

eyebobs to Add Two Additional Optical Retail Locations in 2018

January 3, 2018 —

MINNEAPOLIS—eyebobs has announced its plan to open its second and third retail optical stores in 2018, one in Minnesota and the other in Florida, following up on the fall 2017 debut of the company’s first retail lab in Minneapolis. The main goal of this retail expansion is to increase brand awareness in order to drive traffic to specialty channels including luxury optical stores and specialty stores that currently carry the collection, the company said. “We’re excited to offer the full ‘eyebobs experience’ firsthand,” said eyebobs CEO Mike Hollenstein. “Raising brand awareness through brick-and-mortar outlets will engage both current and new fans. Read More

20/20NOW provides update on recent developments in Tele-Ophthalmology at the annual AAO-IJCAHPO meeting

December 22, 2017 —

New York, NY: – In conjunction with the American Academy of Ophthalmology (AAO) meeting in November, thousands of ophthalmic professionals participated in IJCAHPO’s 45th Annual Continuing Education program in New Orleans, LA, consisting of more than 270 courses and workshops. This year’s participants were given the opportunity to learn from 20/20NOW, the leader in ocular tele-health, on recent developments in telemedicine and specifically tele-ophthalmology. Read More

JINS Eye Exams and Custom Glasses in Under an Hour

January 19, 2016 —

JINS, one of the largest Japanese eyewear makers that recently made presence in the U.S. with its new store near San Francisco’s Union Square, is doing something pretty new for the U.S. market. The company partnered with 20/20 NOW, a novel eye exam provider that uses remote technicians and ophthalmologists, to offer eye exams and custom-made glasses together in under an hour and usually for less than $200.

Read More

Provided by 20/20 NOW, JINS’ San Francisco Store to Start Having Eye Exams

December 8, 2015 —

Japanese eyewear brand, JINS, announced eye exams will be conducted at the JINS Union Square store on 151 Powell Street. These eye exams will be powered by 20/20 NOW’s technology and provided by 20/20 Ophthalmology Services (“20/20”), and take approximately 15 minutes. After customers complete the exam and select frames, they can have prescription glasses made and fitted in another 30 minutes.

Read More

20/20 Vision Center Acquires Eyelogic Assets

November 11, 2015 —

20/20 Vision Center, a provider of remote eye exam systems, recently purchased the worldwide assets of Eyelogic Systems (CNSX: EYE.A), a Calgary, Alberta-based company that develops automated refraction systems, for $521,956 USD.

Read More

Learn more